Drugs / Antipyrine-benzocaine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02153541 Comparator | Apr → Aug 2023 | asthma | Global United Pharmaceutical Corporation | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Antipyrine-benzocaine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02153541 ↗ |
| Route | Topical | “topical auricular anesthesia” NCT02153541 ↗ |